 NEW YORK--BUSINESS WIRE--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Avalon GloboCare Corp. NASDAQ: AVCO and Hebei Senlang Biotechnology Co. Ltd is fair to Avalon shareholders. In connection with the transaction, Avalon will issue 81 million shares of its common stock to acquire SenlangBio. Halper Sadeh encourages Avalon shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at 